Laura NottleBusiness Development Manager at Intertek Pharmaceutical Services
Agenda Sessions
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Control of Impurities and Overall Purity in GalNAc siRNA Conjugates
14:45View SessionKeynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A – Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”
10:15View Session